Ragu Ratnakumaran, MBBS Headshot

Ragu Ratnakumaran, MBBS

Royal Marsden NHS Foundation Trust
Sutton, London

I am a Clinical Oncology Registrar (ST5) in London. I recently undertook my PhD at the Royal Marsden Hospital and Institute of Cancer Research. My research focuses on identifying predictors of late toxicity following stereotactic body radiotherapy (SBRT) for localised prostate cancer, using clinical trial data including the PACE trial.

Disclosures:

  • Employment: none
  • Compensation: none
  • Ownership: none
  • Leadership: none

Presentations

Sep 30

LBA 10 - Two-year toxicity outcomes from PACE-C: Stereotactic Body Radiotherapy (SBRT) versus moderate hypofractionated radiotherapy (MHRT)
Room 22/23
02:40pm - 02:50pm PT